David Shaw’s Gossamer Bio GOSS Stock Holding History
Bought
Maintained
Sold
Other funds holding GOSS
6CM
KCM
David Shaw's GOSS Position: Q2 2026 in Review
David Shaw increased its Gossamer Bio (GOSS) stake by 10,417% in Q2 2026, buying an estimated $11.3M and bringing the position to 511,991 shares worth $6.74M. The position accounts for ﹤0.01% of the portfolio, ranked #2169.
David Shaw first reported a position in GOSS in Q1 2022 and has held it in 14 quarters since. 167 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.
- David Shaw held 511,991 shares of Gossamer Bio worth $6.74M as of Q2 2026.
- David Shaw bought 507,123 Gossamer Bio shares in Q2 2026, an estimated $11.3M.
- Gossamer Bio made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #2169 holding.
- David Shaw first reported a position in Gossamer Bio in Q1 2022 and has held it in 14 quarters since.
- 167 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.